Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)
India · Delayed Price · Currency is INR 451.50
-8.45 (-1.84%)
Jun 8, 2026, 3:29 PM IST
Dr. Agarwal's Health Care Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Dr. Agarwal's Health Care stock has a consensus rating of "Buy" and an average price target of ₹545.00. The average 1-year stock price forecast is 20.71% higher than the current stock price, while the lowest is ₹495.00 (+9.63%) and the highest is ₹610.00 (+35.11%).
Price Target: ₹545.00 (+20.71%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Dr. Agarwal's Health Care stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 5 | 5 |
Financial Forecast
Revenue This Year
25.21B
from 20.80B
Increased by 21.22%
Revenue Next Year
30.50B
from 25.21B
Increased by 20.95%
EPS This Year
5.82
from 4.15
Increased by 40.08%
EPS Next Year
8.25
from 5.82
Increased by 41.78%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 25.4B | ||
| Avg | 25.2B | ||
| Low | 24.6B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 22.3% | ||
| Avg | 21.2% | ||
| Low | 18.3% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 6.00 | ||
| Avg | 5.82 | ||
| Low | 5.50 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 44.5% | ||
| Avg | 40.1% | ||
| Low | 32.5% |